Trials / Unknown
UnknownNCT02726633
Evaluate the Utility of the ProLung China Test in the Diagnosis of Lung Cancer
Evaluate the Utility of the ProLung China Test as Adjunctive to CT Scan in the Diagnosis of Lung Cancer
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 500 (estimated)
- Sponsor
- Chinese Alliance Against Lung Cancer · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
A Study to evaluate the utility of the ProLung China Test as an adjunct to CT scan in the diagnosis of lung cancer.
Detailed description
This Study will assess the stability of the ProLung China Test classification algorithm when used as an adjunct to CT scan. This Study will assess whether there are any potential safety concerns of the ProLung China Test when used to evaluate patients with a positive CT scan for lung cancer.
Conditions
Timeline
- Start date
- 2015-05-01
- Primary completion
- 2017-12-01
- Completion
- 2017-12-01
- First posted
- 2016-04-04
- Last updated
- 2017-04-04
Locations
3 sites across 1 country: China
Source: ClinicalTrials.gov record NCT02726633. Inclusion in this directory is not an endorsement.